The Latest Breaking News from FDA

Reuters Here’s Why HP Shares Are Trading Higher Premarket

Adverum Biotechnologies Inc (NASDAQ: ADVM) received feedback via a 

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.

Vaccine experts are meeting to discuss the U.S. strategy for future COVID-19 booster campaigns

Citius Pharmaceuticals Inc (NASDAQ:CTXR) reported topline results from the Phase 3 trial of I/ONTAK (E7777) for persistent or recurrent cutaneous T-cell lymphoma (CTCL).  I/ONTAK (E7777) is an engineered IL-2-diphtheria toxin fusion protein. No new safety signals were identified.  Citius anticipates filing a marketing application with the FDA in 2H of 2022. The Independent…

The controversy began in September, more than a year into the pandemic, when the Tennessee Board of Medical Examiners issued a warning to doctors in the state: Spreading misinformation about COVID-19 vaccines could land them in big trouble with the board, including the possible revocation of their medical licenses.

The FDA has granted accelerated approval to Novartis AG's (NYSE: NVS) Vijoice (alpelisib) for patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.

The 

Discovering new ways to use existing drugs can come about intentionally or by chance.